Cardiovascular prevention: relationships between arterial aging and chronic drug treatment

Area of Science:

• Cardiovascular Pharmacology
• Vascular Physiology
• Arterial Biomechanics

Background:

• Cardiovascular (CV) prevention drugs are linked to arterial changes, but long-term effects on arterial stiffness and wave reflections are understudied.
• Understanding these drug-specific arterial modifications is crucial for optimizing long-term CV prevention strategies.

Purpose of the Study:

• To determine statistical associations between age-induced changes in arterial stiffness and wave reflections with specific drug classes used in CV prevention.
• To investigate the impact of diuretics, beta-blocking agents, angiotensin II blockers, calcium-channel blockers, insulin therapy, and statins on arterial properties.

Main Methods:

• Studied 347 subjects with hypertension, diabetes mellitus, and hypercholesterolemia undergoing CV prevention.
• Utilized non-invasive tonometry and pulse wave analysis to measure brachial/central blood pressure, aortic pulse wave velocity (PWV), and augmentation index (AIx).
• Compared subgroups based on drug class usage, adjusting for age, sex, mean blood pressure, and other risk factors.

Main Results:

• Calcium-channel blockers and statins showed no association with PWV or AIx.
• Beta-blocking agents were linked to decreased heart rate, increased AIx, and central pulse pressure.
• Diuretics, angiotensin II blockers, and insulin therapy were associated with increased PWV, independent of other factors, suggesting intrinsic arterial wall changes.

Conclusions:

• CV prevention treatments alter arterial properties in a drug-dependent manner.
• Diuretics, angiotensin II blockers, and insulin therapy appear to intrinsically modify the arterial wall, increasing stiffness.
• Beta-blocking agents and insulin therapy are associated with increased central pulse pressure, highlighting differential vascular effects.